Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

296 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Small-molecule inhibitors of Bcl-2 family proteins as therapeutic agents in cancer.
Mohammad R, Giri A, Goustin AS. Mohammad R, et al. Recent Pat Anticancer Drug Discov. 2008 Jan;3(1):20-30. doi: 10.2174/157489208783478676. Recent Pat Anticancer Drug Discov. 2008. PMID: 18289121 Review.
A human B-cell lymphoma line with a de novo multidrug resistance phenotype.
Mohammad RM, Mohamed AN, KuKuruga M, Smith MR, al-Katib A. Mohammad RM, et al. Cancer. 1992 Mar 15;69(6):1468-74. doi: 10.1002/1097-0142(19920315)69:6<1468::aid-cncr2820690626>3.0.co;2-8. Cancer. 1992. PMID: 1540884
Establishment and characterization of a new human Burkitt's lymphoma cell line (WSU-BL).
Mohamed AN, Mohammad RM, Koop BF, al-Katib A. Mohamed AN, et al. Among authors: mohammad rm. Cancer. 1989 Sep 1;64(5):1041-8. doi: 10.1002/1097-0142(19890901)64:5<1041::aid-cncr2820640514>3.0.co;2-c. Cancer. 1989. PMID: 2527086
Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.
Mohamed AN, Nakeff A, Mohammad RM, KuKuruga M, al-Katib A. Mohamed AN, et al. Among authors: mohammad rm. Oncogene. 1988 Oct;3(4):429-35. Oncogene. 1988. PMID: 3152600
Bryostatin 1 induces apoptosis and augments inhibitory effects of vincristine in human diffuse large cell lymphoma.
Mohammad RM, Diwakaran H, Maki A, Emara MA, Pettit GR, Redman B, al-Katib A. Mohammad RM, et al. Leuk Res. 1995 Sep;19(9):667-73. doi: 10.1016/0145-2126(95)00037-o. Leuk Res. 1995. PMID: 7564478
The bcl-2 and p53 oncoproteins can be modulated by bryostatin 1 and dolastatins in human diffuse large cell lymphoma.
Maki A, Diwakaran H, Redman B, al-Asfar S, Pettit GR, Mohammad RM, al-Katib A. Maki A, et al. Among authors: mohammad rm. Anticancer Drugs. 1995 Jun;6(3):392-7. doi: 10.1097/00001813-199506000-00005. Anticancer Drugs. 1995. PMID: 7670136
A unique EBV-negative low-grade lymphoma line (WSU-FSCCL) exhibiting both t(14;18) and t(8;11).
Mohammad RM, Mohamed AN, Smith MR, Jawadi NS, al-Katib A. Mohammad RM, et al. Cancer Genet Cytogenet. 1993 Oct 1;70(1):62-7. doi: 10.1016/0165-4608(93)90132-6. Cancer Genet Cytogenet. 1993. PMID: 8221615
Successful treatment of human Waldenström's macroglobulinemia with combination biological and chemotherapy agents.
Mohammad RM, al-Katib A, Pettit GR, Sensenbrenner LL. Mohammad RM, et al. Cancer Res. 1994 Jan 1;54(1):165-8. Cancer Res. 1994. PMID: 8261437
Antisense oligodeoxyribonucleotide down-regulation of bcl-2 gene expression inhibits growth of the low-grade non-Hodgkin's lymphoma cell line WSU-FSCCL.
Smith MR, Abubakr Y, Mohammad R, Xie T, Hamdan M, al-Katib A. Smith MR, et al. Among authors: mohammad r. Cancer Gene Ther. 1995 Sep;2(3):207-12. Cancer Gene Ther. 1995. PMID: 8528964
Establishment of a human B-CLL xenograft model: utility as a preclinical therapeutic model.
Mohammad RM, Mohamed AN, Hamdan MY, Vo T, Chen B, Katato K, Abubakr YA, Dugan MC, al-Katib A. Mohammad RM, et al. Leukemia. 1996 Jan;10(1):130-7. Leukemia. 1996. PMID: 8558918
296 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback